L. Dasnois

N-Succinyl-(beta-alanyl-L-leucyl-L-alanyl-L-leucyl)doxorubicin: an extracellularly tumor-activated prodrug devoid of intravenous acute toxicity.

D. Shochat, V. Dubois, A. Trouet, 2001, Journal of medicinal chemistry.

CPI-0004Na, a new extracellularly tumor-activated prodrug of doxorubicin: in vivo toxicity, activity, and tissue distribution confirm tumor cell selectivity.

G. Yarranton, D. Shochat, V. Dubois, 2002, Cancer research.

CPI-0004 Na , a New Extracellularly Tumor-Activated Prodrug of Doxorubicin : In Vivo Toxicity , Activity , and Tissue Distribution Confirm Tumor Cell Selectivity 1

G. Yarranton, D. Shochat, V. Dubois, 2002 .

Thimet oligopeptidase (EC 3.4.24.15) activates CPI-0004Na, an extracellularly tumour-activated prodrug of doxorubicin.

B. Reitz, R. Wattiez, T. Nguyen, 2006, European journal of cancer.